Ravi K Amaravadi MD

PubMed

• DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity.
  Huaishan Wang, Shujing Liu, Prithvi Sinha, Fang Liu, Xiaogang Zhang
  Molecular Therapy. 2026-03-04
• Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy.
  Ian Messing, Lauren Linkowski, Matthew D Riina, Melanie Berger, Jonathan Baron
  The Oncologist. 2026-02-15
• Compliance with guidelines and timeliness of sentinel lymph node biopsy for Merkel cell carcinoma treated with Mohs micrographic surgery versus conventional excision a...
  Mara D Trifoi, Karla Valdes Morales, Daniela Frankel, Stephanie K Lin, Annika M Deitermann
  Journal of the American Academy of Dermatology. 2026-02-01

Journal Articles

• Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care Workers  
  Matthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
• Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell Populations  
  Zeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
• Autophagy in malignant transformation and cancer progression  
  Galluzzi L, Pietrocola1 F, Bravo-San Pedro JM, Amaravadi RK, Cecconi F, Codogno P, Debnath J, Karantza V, Kumar S, Levine B, Maiuri MC, Martin S, Penninger J, Piacen..., EMBO J, 1/1/2015

Books/Book Chapters

• Lysosomes, basic mechanisms and roles in disease and drug development. 
  Chapter: Targeting autophagy in cancer therapy. 
  Willis FBEditors: Xiaohong Ma, Shengfu Piao, Quentin Mcafee, Ravi Amaravadi.John Wiley and Sons2014
• Cell Death Signaling in Cancer Biology 
  Chapter: The role of autophagy in drug resistance and potential for therapeutic targeting. Chapter 14 
  Page 87 - 116Editors: Rangwala R, Amaravadi RK.Springer2013

Abstracts/Posters

• Mouse models address key concerns about autophagy inhibition for cancer therapy.
  Amaravadi RK, Debnath J, Cancer Discovery, 1/1/2014
• PUMA: a puzzle piece in chloroquine's antimelanoma activity.
  Amaravadi RK, Journal of Investigative Dermatology, 1/1/2013
• Efficacy, Safety and Pharmacokinetics of a new formulation of the BRAF inhibitor dabrafenib in combination with the MEK1/2 inhibitor trametinib from Part D of a Phase ...
  R. Amaravadi, R. Kudchadkar, R. Gonzalez, D. Lawrence, J. Sosman, J.R. Infante, A. Daud, R. F. Kefford, J. Cebon, W. Sharfman, L. Schuchter, P. Boasberg, K. Lewis, K...., J Clin Oncology; American Society of Clinical Oncology annual meeting, 1/1/2013

Lectures

• Targeting Autophagy in Cancer 
  University of Arizona Cancer Center, Tucson, AZ - 1/1/2015
• Advances in Melanoma 
  1/1/2015
• Targeted therapies for melanoma. 
  1/1/2015